Treatment

Placebo Entresto 24mg/26mg clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic use (Phase IV)
Pulmonary REsistance modification under treatment with Sacubitil/valsartaN in paTients with HeartFailure with reduced ejection fraction
This study looks at how a drug called Entresto affects blood pressure in the lungs and how easily blood flows through them, in people with a type of heart failure where the heart struggles to pump blood.
For: Heart Failure with reduced ejection fraction.
Poland